Author/Creator: Cahn, A. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Cahn, A.

1. Response to: 'baseline differences in SAVOR trial' – prespecified vs. post hoc analysis – a potential source of bias. Issue 12 (December 2015)

Authors:: Raz, I.; Cahn, A.; Mosenzon, O.; Scirica, B. M.; Bhatt, D. L.
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 17:Issue 12(2015:Dec.)
Page Start:: 1203
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Frequency of cancer events with saxagliptin in the SAVOR‐TIMI 53 trial. Issue 2 (27th November 2015)

Authors:: Leiter, L. A.; Teoh, H.; Mosenzon, O.; Cahn, A.; Hirshberg, B.; Stahre, C. A. M.; Hoekstra, J. B. L.; Alvarsson, M.; Im, K.; Scirica, B. M.; Bhatt, D. L.; Raz, I.
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 18:Issue 2(2016)
Page Start:: 186
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Use of autologous radiolabelled neutrophils to quantify lung neutrophil retention in healthy volunteers, experimental LPS-induced lung inflammation, and COPD. (November 2017)

Authors:: Tregay, N.; Begg, M.; Cahn, A.; Povey, K.; Madhavan, S.; Simmonds, R.; Wilson, F.; Peters, A.M.; Hessel, E.M.; Chilvers, E.
Journal:: Respiratory medicine
Issue:: Volume 132(2017)
Page Start:: 271
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD. (October 2017)

Authors:: Cahn, A.; Hamblin, J.N.; Begg, M.; Wilson, R.; Dunsire, L.; Sriskantharajah, S.; Montembault, M.; Leemereise, C.N.; Galinanes-Garcia, L.; Watz, H.; Kirsten, A.M.; Fuhr, R.; Hessel, E.M.
Journal:: Pulmonary pharmacology & therapeutics
Issue:: Volume 46(2017:Oct.)
Page Start:: 69
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Impact of treatment with saxagliptin on glycaemic stability and β‐cell function in the SAVOR‐TIMI 53 study. Issue 5 (25th February 2015)

Authors:: Leibowitz, G.; Cahn, A.; Bhatt, D. L.; Hirshberg, B.; Mosenzon, O.; Wei, C.; Jermendy, G.; Sheu, W. H.‐H.; Sendon, J. L.; Im, K.; Braunwald, E.; Scirica, B. M.; Raz, I.
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 17:Issue 5(2015:May)
Page Start:: 487
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Randomized trial of allergen‐induced asthmatic response in smokers and non‐smokers: effects of inhaled corticosteroids. Issue 10 (15th September 2015)

Authors:: Cahn, A.; Boyce, M.; Mistry, S.; Musani, N.; Rambaran, C.; Storey, J.; Ventresca, P.; Michel, O.
Journal:: Clinical & experimental allergy
Issue:: Volume 45:Issue 10(2015:Oct.)
Page Start:: 1531
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗